{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:54:32Z","timestamp":1779256472266,"version":"3.51.4"},"reference-count":91,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.jdiacomp.2018.04.010","type":"journal-article","created":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T02:57:26Z","timestamp":1524797846000},"page":"708-712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["A review of bone metabolism and developments in medical treatment of the diabetic Charcot foot"],"prefix":"10.1016","volume":"32","author":[{"given":"Rasmus Bo","family":"Jansen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole Lander","family":"Svendsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0005","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.1002\/dmrr.848","article-title":"Practical guidelines on the management and prevention of the diabetic foot: based upon the International Consensus on the Diabetic Foot (2007) prepared by the International Working Group on the Diabetic Foot","volume":"24","author":"Apelqvist","year":"2008","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0010","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2337\/dc16-2042","article-title":"Diabetic neuropathy: a position statement by the American Diabetes Association","volume":"40","author":"Pop-Busui","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0015","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.jdiacomp.2015.06.014","article-title":"Prevalence of neuropathy in type 2 diabetic patients and its association with other diabetes complications: the Verona Diabetic Foot Screening Program","volume":"29","author":"Salvotelli","year":"2015","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0020","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s10016-003-0039-5","article-title":"Charcot joint disease in diabetes mellitus","volume":"17","author":"Lee","year":"2003","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0025","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.mcna.2013.04.003","article-title":"The Charcot foot","volume":"97","author":"Rogers","year":"2013","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0030","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1002\/dmrr.846","article-title":"Charcot neuro-osteoarthropathy-current standards","volume":"24","author":"Petrova","year":"2008","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0035","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF00283741","article-title":"The diabetic leg","volume":"22","author":"Ward","year":"1982","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0040","doi-asserted-by":"crossref","first-page":"437","DOI":"10.7547\/1010437","article-title":"The Charcot foot in diabetes","volume":"101","author":"Rogers","year":"2011","journal-title":"J Am Podiatr Med Assoc"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0045","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1177\/1071100714543649","article-title":"Charcot arthropathy of the foot and ankle in patients with idiopathic neuropathy","volume":"35","author":"Bariteau","year":"2014","journal-title":"Foot Ankle Int"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0050","doi-asserted-by":"crossref","first-page":"796","DOI":"10.2337\/diacare.23.6.796","article-title":"Long-term follow-up in diabetic Charcot feet with spontaneous onset","volume":"23","author":"Fabrin","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0055","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/S0140-6736(02)11671-0","article-title":"The Charcot foot","volume":"360","author":"Hartemann-Heurtier","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0060","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s00125-002-0885-7","article-title":"Charcot neuroarthropathy in diabetes mellitus","volume":"45","author":"Rajbhandari","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0065","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/dmrr.2734","article-title":"Acute Charcot neuro-osteoarthropathy","volume":"32","author":"Petrova","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0070","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/j.1464-5491.2005.01677.x","article-title":"The perils of procrastination: effects of early vs. delayed detection and treatment of incipient Charcot fracture","volume":"22","author":"Chantelau","year":"2005","journal-title":"Diabet Med J Br Diabet Assoc"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0075","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1055\/s-2006-924229","article-title":"Evaluation of the diabetic charcot foot by MR imaging or plain radiography--an observational study","volume":"114","author":"Chantelau","year":"2006","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0080","article-title":"Is the Eichenholtz classification still valid for the diabetic Charcot foot?","volume":"144","author":"Chantelau","year":"2014","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0085","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40842-015-0018-0","article-title":"Charcot stage 0: A review and consideratons for making the correct diagnosis early","volume":"1","author":"Holmes","year":"2015","journal-title":"Clin Diabetes Endocrinol"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0090","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.2337\/dc09-1428","article-title":"Mortality associated with acute Charcot foot and neuropathic foot ulceration","volume":"33","author":"van Baal","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0095","first-page":"492","article-title":"Health-related quality of life in patients with Charcot foot","volume":"32","author":"Pinzur","year":"2003","journal-title":"Am J Orthod"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0100","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1177\/107110070502600203","article-title":"Health related quality of life, cognitive function, and depression in diabetic patients with foot ulcer or amputation. A preliminary study","volume":"26","author":"Willrich","year":"2005","journal-title":"Foot Ankle Int Am Orthop Foot Ankle Soc Swiss Foot Ankle Soc"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0105","first-page":"1591","article-title":"Charcot foot: the diagnostic dilemma","volume":"64","author":"Sommer","year":"2001","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0110","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1177\/1938640012451234","article-title":"Charcot Arthropathy","volume":"5","author":"Frykberg","year":"2012","journal-title":"Foot Ankle Spec"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0115","doi-asserted-by":"crossref","DOI":"10.3402\/dfa.v2i0.6418","article-title":"An overview of conservative treatment options for diabetic Charcot foot neuroarthropathy","volume":"2","author":"Ramanujam","year":"2011","journal-title":"Diabet Foot Ankle"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0120","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1757-1146-6-30","article-title":"Developing an evidence-based clinical pathway for the assessment, diagnosis and management of acute Charcot Neuro-Arthropathy: a systematic review","volume":"6","author":"Milne","year":"2013","journal-title":"J Foot Ankle Res"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0125","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1177\/107110070502601101","article-title":"An analysis of iatrogenic complications from the total contact cast","volume":"26","author":"Guyton","year":"2005","journal-title":"Foot Ankle Int"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0130","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1463-1326.2012.01671.x","article-title":"Medical management of Charcot arthropathy","volume":"15","author":"Petrova","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0135","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00402-006-0271-x","article-title":"\u201cSilent\u201d bone stress injuries in the feet of diabetic patients with polyneuropathy: a report on 12 cases","volume":"127","author":"Chantelau","year":"2007","journal-title":"Arch Orthop Trauma Surg"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0140","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jdiacomp.2012.05.006","article-title":"Duration of off-loading and recurrence rate in Charcot osteo-arthropathy treated with less restrictive regimen with removable walker","volume":"26","author":"Christensen","year":"2012","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0145","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1056-8727(98)00006-3","article-title":"Acute Charcot arthropathy in patients with diabetes mellitus: healing times by foot location","volume":"12","author":"Sinacore","year":"1998","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0150","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00003086-200506000-00026","article-title":"How effective is intensive nonoperative initial treatment of patients with diabetes and Charcot arthropathy of the feet?","volume":"435","author":"Saltzman","year":"2005","journal-title":"Clin Orthop"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0155","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00125-011-2354-7","article-title":"Audit of acute Charcot's disease in the UK: the CDUK study","volume":"55","author":"Game","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0160","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.2337\/diacare.26.9.2595","article-title":"Activity patterns of patients with diabetic foot ulceration: patients with active ulceration may not adhere to a standard pressure off-loading regimen","volume":"26","author":"Armstrong","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0165","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/1071100712464957","article-title":"Recurrence of acute Charcot neuropathic osteoarthropathy after conservative treatment","volume":"34","author":"Osterhoff","year":"2013","journal-title":"Foot Ankle Int"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0170","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/dme.12347","article-title":"The effect of diabetic neuropathy on foot bones: a systematic review and meta-analysis","volume":"31","author":"Barwick","year":"2014","journal-title":"Diabet Med J Br Diabet Assoc"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0175","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00198-006-0253-4","article-title":"Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes\u2014a meta-analysis","volume":"18","author":"Vestergaard","year":"2007","journal-title":"Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0180","doi-asserted-by":"crossref","DOI":"10.1007\/s40618-018-0828-x","article-title":"Comparison of osteoporosis in US adults with type 1 and type 2 diabetes mellitus","author":"DeShields","year":"2018","journal-title":"J Endocrinol Investig"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0185","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/BF03324857","article-title":"Diabetes and osteoporosis","volume":"20","author":"Saller","year":"2008","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0190","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00223-008-9195-5","article-title":"Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes","volume":"84","author":"Vestergaard","year":"2009","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0195","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s00125-014-3289-6","article-title":"Fracture risk in diabetic elderly men: the MrOS study","volume":"57","author":"Napoli","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0200","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10654-012-9674-x","article-title":"Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies","volume":"27","author":"Ma","year":"2012","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0205","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1210\/jc.2016-3282","article-title":"Bone turnover is suppressed in insulin resistance, independent of adiposity","volume":"102","author":"Tonks","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0210","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1365-2265.2007.03159.x","article-title":"Reduced attenuation of bone resorption after oral glucose in type 2 diabetes","volume":"68","author":"Chailurkit","year":"2008","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0215","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1007\/s00198-005-1877-5","article-title":"Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus","volume":"16","author":"Gerdhem","year":"2005","journal-title":"Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0220","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00198-011-1595-0","article-title":"Bone structure and turnover in type 2 diabetes mellitus","volume":"23","author":"Shu","year":"2012","journal-title":"Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0225","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.bone.2017.05.004","article-title":"The association between insulin use and volumetric bone mineral density, bone micro-architecture and bone strength of the distal radius in patients with type 2 diabetes - the Maastricht study","volume":"101","author":"de Waard","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0230","first-page":"1194","article-title":"Influence of age, sex, and insulin on osteoblast function: osteoblast dysfunction in diabetes mellitus","volume":"80","author":"Bouillon","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0235","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/1759720X16687480","article-title":"Diabetes and bone health: latest evidence and clinical implications","volume":"9","author":"Sundararaghavan","year":"2017","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0240","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/j.1464-5491.2005.01510.x","article-title":"Calcaneal bone mineral density in patients with Charcot neuropathic osteoarthropathy: differences between Type 1 and Type 2 diabetes","volume":"22","author":"Petrova","year":"2005","journal-title":"Diabet Med J Br Diabet Assoc"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0245","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2522\/ptj.20080025","article-title":"Inflammatory osteolysis in diabetic neuropathic (charcot) arthropathies of the foot","volume":"88","author":"Sinacore","year":"2008","journal-title":"Phys Ther"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0250","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1464-5491.2001.00511.x","article-title":"Calcaneal ultrasonometry in patients with Charcot osteoarthropathy and its relationship with densitometry in the lumbar spine and femoral neck and with markers of bone turnover","volume":"18","author":"Jirkovsk\u00e1","year":"2001","journal-title":"Diabet Med J Br Diabet Assoc"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0255","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1053\/j.jfas.2011.05.005","article-title":"Trabecular quality and cellular characteristics of normal, diabetic, and charcot bone","volume":"50","author":"La Fontaine","year":"2011","journal-title":"J Foot Ankle Surg"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0260","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2337\/diacare.18.1.34","article-title":"Osteopenia, neurological dysfunction, and the development of Charcot neuroarthropathy","volume":"18","author":"Young","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0265","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1460-9584.2000.00225.x","article-title":"Is diabetic Charcot foot related to lower limb osteopaenia?","volume":"6","author":"Clasen","year":"2000","journal-title":"Foot Ankle Surg"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0270","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2337\/dc10-2315","article-title":"Loss of RAGE defense: a cause of Charcot neuroarthropathy?","volume":"34","author":"Witzke","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0275","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jdiacomp.2017.02.005","article-title":"Persistent inflammation with pedal osteolysis 1year after Charcot neuropathic osteoarthropathy","volume":"31","author":"Sinacore","year":"2017","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0280","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1475-097X.2009.00915.x","article-title":"Bone mineral density in diabetes mellitus patients with and without a Charcot foot","volume":"30","author":"Christensen","year":"2010","journal-title":"Clin Physiol Funct Imaging"},{"issue":"2","key":"10.1016\/j.jdiacomp.2018.04.010_bb0285","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jdiacomp.2017.11.004","article-title":"Bone mineral density and markers of bone turnover and inflammation in diabetes patients with or without a Charcot foot: an 8.5-year prospective case-control study","volume":"32","author":"Jansen","year":"2018","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0290","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00223-016-0175-x","article-title":"Epidemiology of fractures in diabetes","volume":"100","author":"Starup-Linde","year":"2017","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0295","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/(SICI)1096-9136(199707)14:7<527::AID-DIA404>3.0.CO;2-Q","article-title":"Measurement of markers of osteoclast and osteoblast activity in patients with acute and chronic diabetic Charcot neuroarthropathy","volume":"14","author":"Gough","year":"1997","journal-title":"Diabet Med J Br Diabet Assoc"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0300","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/dme.12590","article-title":"Inflammatory and bone turnover markers in a cross-sectional and prospective study of acute Charcot osteoarthropathy","volume":"32","author":"Petrova","year":"2015","journal-title":"Diabet Med J Br Diabet Assoc"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0305","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13047-015-0096-3","article-title":"IL-17 cytokines in bone healing of diabetic Charcot arthropathy patients: a prospective 2\u202fyear follow-up study","volume":"8","author":"Folestad","year":"2015","journal-title":"J Foot Ankle Res"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0310","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13047-015-0129-y","article-title":"Offloading treatment is linked to activation of proinflammatory cytokines and start of bone repair and remodeling in Charcot arthropathy patients","volume":"8","author":"Folestad","year":"2015","journal-title":"J Foot Ankle Res"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0315","first-page":"S11","article-title":"Local and systemic concentration of pro-inflammatory cytokines, osteoprotegerin, sRANKL and bone turnover markers in acute Charcot foot and in controls","volume":"54","author":"Divyateja","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0320","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1177\/107110070602701007","article-title":"Cytokine-induced osteoclastic bone resorption in charcot arthropathy: an immunohistochemical study","volume":"27","author":"Baumhauer","year":"2006","journal-title":"Foot Ankle Int"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0325","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2337\/dc09-1141","article-title":"Proinflammatory modulation of the surface and cytokine phenotype of monocytes in patients with acute Charcot foot","volume":"33","author":"Uccioli","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0330","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1210\/endo.142.12.8536","article-title":"Minireview: the OPG\/RANKL\/RANK system","volume":"142","author":"Khosla","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0335","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jama.292.4.490","article-title":"Clinical implications of the osteoprotegerin\/RANKL\/RANK system for bone and vascular diseases","volume":"292","author":"Hofbauer","year":"2004","journal-title":"JAMA J Am Med Assoc"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0340","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.2337\/db10-1220","article-title":"The RANKL\/RANK\/OPG signaling pathway mediates medial arterial calcification in diabetic Charcot neuroarthropathy","volume":"60","author":"Ndip","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0345","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1007\/s00125-004-1477-5","article-title":"Vascular calcification and osteolysis in diabetic neuropathy-is RANK-L the missing link?","volume":"47","author":"Jeffcoate","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0350","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00223-003-0011-y","article-title":"Novel aspects on RANK ligand and osteoprotegerin in osteoporosis and vascular disease","volume":"74","author":"Sattler","year":"2004","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0355","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00125-008-0992-1","article-title":"Increased osteoclastic activity in acute Charcot's osteoarthropathy: the role of receptor activator of nuclear factor-kappaB ligand","volume":"51","author":"Mabilleau","year":"2008","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.jdiacomp.2018.04.010_bb0360","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00223-013-9820-9","article-title":"Novel use of a Dektak 150 surface profiler unmasks differences in resorption pit profiles between control and Charcot patient osteoclasts","volume":"94","author":"Petrova","year":"2014","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0365","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/917945","article-title":"Inhibition of TNF-\u03b1 reverses the pathological resorption pit profile of osteoclasts from patients with acute Charcot osteoarthropathy","volume":"2015","author":"Petrova","year":"2015","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0370","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/17453674.2015.1033606","article-title":"Role of Wnt\/\u03b2-catenin and RANKL\/OPG in bone healing of diabetic Charcot arthropathy patients","volume":"86","author":"Folestad","year":"2015","journal-title":"Acta Orthop"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0375","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1464-5491.2010.02940.x","article-title":"Plasma osteoprotegerin concentrations in peripheral sensory neuropathy in type 1 and type 2 diabetic patients","volume":"27","author":"Nybo","year":"2010","journal-title":"Diabet Med J Br Diabet Assoc"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0380","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/s-0028-1085425","article-title":"Plasma osteoprotegerin concentrations in type 2 diabetic patients and its association with neuropathy","volume":"117","author":"Terekeci","year":"2009","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"8","key":"10.1016\/j.jdiacomp.2018.04.010_bb0385","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.jdiacomp.2016.07.008","article-title":"High osteoprotegerin is associated with development of foot ulcer in type 1 diabetes","volume":"30","author":"Zobel","year":"2016","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0390","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/S0002-9440(10)63560-2","article-title":"Receptor activator of nuclear factor kappaB ligand (RANKL)\/osteoprotegerin (OPG) ratio is increased in severe osteolysis","volume":"163","author":"Grimaud","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0395","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1007\/s001250100008","article-title":"Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial","volume":"44","author":"Jude","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0400","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.2337\/diacare.28.5.1214","article-title":"Six-month treatment with alendronate in acute Charcot neuroarthropathy: a randomized controlled trial","volume":"28","author":"Pitocco","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0405","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1053\/j.jfas.2004.07.005","article-title":"Bisphosphonates for the treatment of Charcot neuroarthropathy","volume":"43","author":"Anderson","year":"2004","journal-title":"J Foot Ankle Surg"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0410","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.2337\/dc11-0396","article-title":"The effect of zoledronic acid on the clinical resolution of Charcot neuroarthropathy: a pilot randomized controlled trial","volume":"34","author":"Pakarinen","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0415","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1007\/s00125-012-2507-3","article-title":"Treatment of acute Charcot foot with bisphosphonates: a systematic review of the literature","volume":"55","author":"Richard","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2016.03.012","article-title":"Zoledronic acid increases the circulating soluble RANKL level in mice, with a further increase in lymphocyte-derived soluble RANKL in zoledronic acid- and glucocorticoid-treated mice stimulated with bacterial lipopolysaccharide","volume":"83","author":"Abe","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0425","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.fas.2012.12.007","article-title":"Effect of immobilization, off-loading and zoledronic acid on bone mineral density in patients with acute Charcot neuroarthropathy: a prospective randomized trial","volume":"19","author":"Pakarinen","year":"2013","journal-title":"Foot Ankle Surg"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0430","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.2337\/dc06-0376","article-title":"Intranasal calcitonin in the treatment of acute Charcot neuroosteoarthropathy: a randomized controlled trial","volume":"29","author":"Bem","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0435","first-page":"S44","article-title":"The effect of teriparatide [human parathyroid hormone (1-34)] therapy on fracture healing in Charcot neuroarthropathy of lower extremity","volume":"16","author":"Brosky","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0440","series-title":"Abstr EASD","first-page":"985","article-title":"Treatment with parathyroid hormone does not enhance clinical resolution and fracture healing of Charcot osteoarthropathy: double blind randomised placebo controlled trial","author":"Petrova","year":"2016"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0445","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.2337\/dc17-1517","article-title":"Effect of single dose of RANKL antibody treatment on acute Charcot neuro-osteoarthropathy of the foot","volume":"41","author":"Busch-Westbroek","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0450","series-title":"Abstr Diabet Foot Aust Conf","first-page":"6","article-title":"Preliminary (12-week) results from trial of Denosumab for acute diabetic Charcot neuroarthropathy","author":"Lau","year":"2017"},{"key":"10.1016\/j.jdiacomp.2018.04.010_bb0455","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1056\/NEJMe1711298","article-title":"Romosozumab - promising or practice changing?","volume":"377","author":"Rosen","year":"2017","journal-title":"N Engl J Med"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872718302393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872718302393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T04:18:32Z","timestamp":1571285912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872718302393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":91,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S1056872718302393"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2018.04.010","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review of bone metabolism and developments in medical treatment of the diabetic Charcot foot","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2018.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}